Cardiovascular Thoracic Surgeon is accepting 250 CCSVI patients to observe treatment for M.S.

2 Studies - A) Pre and Post treatment study (involves ultrasounds, trial on 250 patients)
B) Follow up of anyone who has received treatment - (no patient limit)

To collect more statistics regarding the procedure.


***phone lines are busy so please be patient***

or you can email:

Angela Legace - Chief Stenographer and Office Manager - This email address is being protected from spambots. You need JavaScript enabled to view it.


Dr. Juurlink's study back in 1998 was silenced like so many others that linked the vascular connection to Multiple Sclerosis. This research was done at the Cameco MS Neuroscience Research Centre in Saskatoon. The MS Society of Canada was sponsoring this centre for MS research and also dismissed his findings. Dr Juurlink is now involved with the CCSVI advocacy. His work will not be silenced again by Neurologists.

He will be speaking at the 1st Annual National CCSVI Society Conference as well as other Doctors about their facts and research about CCSVI and now how this ties into other Neurodegenative diseases.

Dr. Bill Code who was born and raised in Saskatchewan has known Dr. Bernie Juurlink for 30 years. Dr Code as you remember has MS and has speaking all over Canada the past year since he was treated for CCSVI. Dr. Juurlink expressed his keen interest to join the ongoing efforts of doctors and researchers around the world to uncover the full potential of CCSVI and its relationship to neurodegenerative diseases.

Dr. Code worked with Dr. Juurlink in stroke research early in their careers. In the mid-1990’s, Dr. Juurlink went on to examine at a micro level the role of several cellular factors in creating areas of low oxygen in the brain and resulting damage.

Here’s an abstract of one of his early papers:

The multiple sclerosis lesion: initiated by a localized hypoperfusion in a central nervous system where mechanisms allowing leukocyte infiltration are readily upregulated?

B. H. J. Juurlink
Medical Hypotheses, Volume 51, Issue 4, October 1998, Pages 299-303

A mechanism is proposed that may explain the factors that initiate a multiple sclerosis (MS) lesion. It is based upon the following two hypotheses: (i) there is a lower stimulus threshold for upregulating the mechanisms that result in leukocyte infiltration in individuals predisposed to developing MS; (ii) the MS lesion is initiated as a reduction in blood flow to a localized region of white matter. This reduction in blood flow leads to: (a) degenerative white matter changes affecting oligodendrocytes; (b) upregulation of chemokines in the endothelial cells and/or glial cells; and (c) upregulation of cell adhesion molecules on endothelial cells. Signals from the hypoxemic and hypoglycemic glial cells, likely involving myelin molecules and cytokines, result in an inflammatory immune response that results in rampant demyelination. Evidence supporting the proposed mechanism is presented, as well as suggestions on how to test the validity of the proposal.

Dr. Juurlink was interviewed by Avis Favaro in her original W5 series on CCSVI. He is one of the pioneers of this emerging theory and we are delighted he agreed to speak at our New Discoveries, New Beginnings Canadian CCSVI Conference.


Dear Family, Friends and Fellows;

The government’s recent approval of funding for clinical trials in Canada was a step in the right direction. It admits to the connection between Chronic Cerebral Spinal Venous Insufficiency (CCSVI )and Multiple Sclerosis (M.S.).

These trials, although a step in the right direction also ignore the fact that people with M.S. cannot afford to wait the time it will take to:

A/ start the trials –where, when, who will perform the trials, which candidates to participate

B/ complete the trials

C/ decide on a direction to take after the trials.

This in all reality will take many years to achieve. While this happens, we will lose over 400 lives a year to this disease. People will become more disabled .The suffering will continue. This procedure is performed every day in this country. It is approved for people without M.S. It is denied for people with M.S. Is this not discrimination in its purest form? With over 13000 of these procedures performed in 50 countries to date, and 2/3 of the people with improvements is this not enough evidence to allow this procedure in this country now?

Why is there no registry? Dr. Kirsty Duncan (M.P of Etobicoke) has been asking for this for a very long time. A registry would show the evidence necessary to allow this procedure to be approved. There would be thousands of lives saved and millions of dollars saved by using the proof that is already at hand.

So, why clinical trials? 200 people in a double blinded study.( 100 people receive the procedure the other 100 get a placebo). Angioplasty is not a drug. It is an approved and proven medical procedure.

The people who control the direction of this procedure in Canada must be delaying it for a reason. There is no real obstacle in the way of allowing this simple proven procedure in Canada.

My final thought, I think it's criminal to let people suffer and die, knowing it can be ended today.

Steve Garvie